Extraperitoneal Robot-Assisted Radical Prostatectomy with the Hugo™ RAS System: Initial Experience at a High-Volume...

Area of Science:

• Urology
• Surgical Technology
• Robotic Surgery

Background:

• The Hugo™ Robotic-Assisted Surgery (RAS) system is a new robotic platform.
• Data on extraperitoneal robot-assisted radical prostatectomy (eRARP) using the Hugo™ RAS system is limited.
• This study addresses the need for more evidence on this specific application.

Purpose of the Study:

• To evaluate the safety and feasibility of eRARP using the Hugo™ RAS system.
• To report comprehensive outcomes of eRARP performed with the Hugo™ RAS system.
• To analyze the largest reported cohort of eRARP using this novel robotic platform.

Main Methods:

• Prospective study of 50 consecutive prostate cancer patients undergoing eRARP ± lymph node dissection.
• Procedures performed using a modular four-arm Hugo™ RAS system.
• Surgeons had limited prior experience with robotic surgery.

Main Results:

• No intraoperative complications were recorded in 50 cases.
• Two major complications occurred within 90 days post-surgery.
• At 3 months, 72% achieved undetectable PSA, 66% social continence, and 40% erectile function.

Conclusions:

• Extraperitoneal robot-assisted radical prostatectomy (eRARP) using the Hugo™ RAS system is safe and effective.
• The system shows promise for oncologic control and functional recovery.
• Further research with larger cohorts and longer follow-up is needed.